Skip to main content

Table 3 The Tarragona strategy

From: Bench-to-bedside review: Therapeutic options and issues in the management of ventilator-associated bacterial pneumonia

Point Details
1 Antibiotic therapy should be started immediately
2 Antibiotic choice can be targeted, in some cases, based on direct staining
3 The prescription should be modified in accordance with microbiologic findings
4 Prolonging antibiotic treatment does not prevent recurrence
5 Patients with chronic obstructive pulmonary disease or 1 week of intubation should receive combination therapy because of the risk for ventilator-associated pneumonia caused by Pseudomonas aeruginosa
6 Methicillin-resistant Staphylococcus aureus is not anticipated in the absence of antibiotic exposure, whereas methicillin-sensitive S aureus should be strongly suspected in comatose patients
7 Therapy against yeast is not required, even in case of colonization with Candida spp.
8 Vancomycin administration for Gram-positive pneumonias is associated with very poor outcome
9 The specific choice of agent should avoid the regimen to which each patient has previously been exposed
10 Guidelines should be updated regularly and customized in accordance with local patterns
  1. Modified from Sandiumenge and coworkers [41].